Products for Research Use Only
RegisterLogin

Botensilimab

CAT: 0804-HY-P99484-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99484-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer[1].
CAS Number
2408310-37-0
Product Name Alternative
AGEN 1181
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/botensilimab.html
Purity
99.00
Solubility
H2O
Smiles
[Botensilimab]
Molecular Weight
(144.54 kDa)
References & Citations
[1]Delepine C, et, al. 470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and I-O refractory tumors FREE.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
abx831612-01Botensilimab
GTR18337838-01Botensilimab Antibody
MBS1586381-01Botensilimab ELISA Kit
HB651076-01Research Grade Botensilimab
E55B0773Botensilimab (Reference antibody)
A138330Botensilimab Biosimilar (Monoclonal, IgG1)
ICH5412-25mgBotensilimab Biosimilar - Research Grade
21-890Botensilimab - Research Grade Biosimilar
GTR18697396-01Botensilimab Human Monoclonal Antibody
GTR18780443-01(Botensilimab) Biosimilar Reference Antibody

Popular Products